Table 1.
Challenge microorganism | Biofilm growth medium (BGM) | Model | Test methodology | Dressings tested (Table 2) |
---|---|---|---|---|
Antibiotic-resistant Pseudomonas aeruginosa NCTC 13437 Community-acquired Methicillin-resistant Staphylococcus aureus (CA-MRSA) USA300 Candida albicans NCPF 3179 |
Foetal calf serum (FCS) | Simple biofilm model | Elemental analysis (K+, Mg2+, Ca2+, Zn2+, Ag+) of residual biofilm after dressing being applied for 24 hours (a simple and chemically consistent model to investigate formulation effects) (n = 6) | CMC SCMC NGAD |
Antibiotic-resistant P. aeruginosa NCTC 8506 |
Elemental analysis (Ag+) and quantitative live/dead staining after dressing being applied for 48 hours (a more challenging strain and longer dressing exposure time selected to challenge the silver-containing dressings) (n = 9) | NGAD NCSD SNAD |
||
| ||||
S. aureus (clinical wound isolate, CI72) and Klebsiella pneumoniae (clinical isolate, CI45) | TSB : FCS (50 : 50) | Simulated wound polymicrobial biofilm model | Quantitative microbiology (total viable counts), PNA FISH, live/dead and Calcofluor White staining after dressing application for 48 hours (a more complex inoculum and longer dressing exposure time selected to challenge the silver dressings) (n = 5) | NGAD NCSD SNAD |